Labcorp Reports Higher 2Q 2026 Profit and Cuts Share Repurchase Costs
Labcorp beat quarterly earnings expectations and raised 2026 guidance, citing growth in core business and oncology. The company announced a $1.0 billion increase in its share repurchase program.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day